About CyberHeart
CyberHeart is a Healthcare company based in Menlo Park (United States) founded in 2006, and was acquired by Varian Medical Systems in May 2019. Non-invasive radiosurgical system for cardiac arrhythmia treatment is developed. It operates in the Healthcare and Industrial Goods & Manufacturing sectors. CyberHeart has raised $11.17 million across 3 funding rounds from investors including Varian, Mitsubishi Corporation and Emergent Medical Partners. The company has 1 employees. The company was acqui-hired. Its focus areas include High Tech, Professional Service Robots, Surgery and Life Sciences. Its legal entity is CYBERHEART INC. Its competitors include PROCEPT BioRobotics, Auris Health and Intuitive; 3 of its 3 listed competitors have raised funding.
Company details
CyberHeart was founded in 2006 and is based in Menlo Park, United States. The company operates in the medical technology sector, where a non-invasive robotic ablation system for cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia, is being developed. Heart and patient movement is dynamically detected, tracked, and compensated for to ensure precise radiation delivery. The system is intended for use by radiation oncologists, medical physicists, electrophysiologists, and cardiac surgeons.
- Headquarters Menlo Park, United States
- Employees 1
- Stage Acquired
- SectorsHealthcareIndustrial Goods & Manufacturing
- Website cyberheartinc.com
- Social LinkedIn
- Acquired by Varian Medical Systems (May 2019)
- Legal Name Cyberheart Inc
- Total Equity Funding$11.17M (USD)
in 3 rounds
- Latest Funding Round$2.17M (USD), Series A
Feb 2011
- InvestorsVarian
& 5 more
- Employee Count1
- Acquired byVarian Medical Systems
(May 2019)
Funding Insights of CyberHeart
CyberHeart has successfully raised a total of $11.17M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $2.17 million completed in February 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $11.17M
- Total Rounds 3
- Last Round Series A — $2.17M
- First Round $9M
(Jan 2008)
- Investors Count 5
All 3 funding rounds of CyberHeart with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2011 | $2.17M | Series A | – | – | – |
| Nov 2009 | $3.6M | Debt – Venture | – | – | |
| Jan 2008 | $9M | Series A | – | Emergent Medical Partners |
6 investors in total: 6 institutional.
Investors in CyberHeart
CyberHeart has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Varian, Mitsubishi Corporation and Emergent Medical Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Funding and expertise are provided for medical device development. | 2017 | emvllp.com | San Jose, United States | |
Venture capital is invested in AI, energy, and various sectors. | mucap.co.jp | Tokyo, Japan | ||
Solutions for technology and communication needs are provided by United Investment LTD. | ui-ltd.com | |||
| venture-select.com | ||||
Natural gas and petroleum are distributed and traded globally. | 1954 | mitsubishicorp.com | New York, United States | |
Varian is focused on developing cancer treatment technologies. | 1948 | varian.com | Palo Alto, United States |
Investor details for CyberHeart
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of CyberHeart
4 dated milestones of CyberHeart across 13 years, from founding to its latest funding, stage changes and deals.
- Founded CyberHeart is founded.
- Funding First funding round of $9.0M.
- Funding Latest funding round, Series A, of $2.2M.
- Exit Acquired by Varian Medical Systems.
Competitors of CyberHeart
CyberHeart has 3 listed competitors in our database, 3 of them funded. They include PROCEPT BioRobotics, Auris Health and Intuitive.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| procept-biorobotics.com | 2009 | Redwood, United States | $348.84M | 217 | Robotic waterjet system for prostate tissue removal is developed. | |
| aurishealth.com | 2007 | Redwood, United States | $733.62M | 242 | Robotic microsurgical systems for endoscopy are developed. | |
| intuitive.com | 1995 | Sunnyvale, United States | $17M | 15 | Robotic-assisted surgical systems are developed for minimally invasive procedures. |
Detailed competitors of CyberHeart
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Medical Equipment & Supplies
3 companies that operate in the same segment as CyberHeart (Medical Equipment & Supplies) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | USD 3.07 B | 10,600 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cyberheart
Complete news archive for CyberHeart
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CyberHeart
CyberHeart was founded in 2006 and raised its 1st funding round 2 years after it was founded.
CyberHeart is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
CyberHeart is a funded company, having raised a total of $11.17M across 3 funding rounds to date. The company's 1st funding round was a Series A of $9M, raised on Jan 2008.
CyberHeart has 1 employees.
CyberHeart was founded in 2006 and is based in Menlo Park, United States. The company operates in the medical technology sector, where a non-invasive robotic ablation system for cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia, is being developed. Heart and patient movement is dynamically detected, tracked, and compensated for to ensure precise radiation delivery. The system is intended for use by radiation oncologists, medical physicists, electrophysiologists, and cardiac surgeons.
CyberHeart's top competitors include PROCEPT BioRobotics, Auris Health and Intuitive.
CyberHeart has 6 investors. Key investors include Varian, Mitsubishi Corporation, Emergent Medical Partners, Mitsubishi UFJ Capital, and United Investment LTD.
CyberHeart operates through Cyberheart Inc.
Yes. CyberHeart was acquired by Varian Medical Systems in May 2019.